Peer-reviewed article

Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.

Madsen MK, Fisher PM, Burmester D, Dyssegaard A, Stenbæk DS iD, Kristiansen S, Johansen SS, Lehel S, Linnet K, Svarer C iD, Erritzoe D iD, Ozenne B, Knudsen GM iD

Neuropsychopharmacology : official publication of the American College of NeuropsychopharmacologyJun 1, 2019Denmark, United Kingdom16 citationsDOI: 10.1038/s41386-019-0360-5

Abstract

The original version of this article contained an error in the labelling of Figures 2 and 3. While the captions and figures themselves are correct, in order to correspond with the in-text references, they have now been re-numbered in both the PDF and HTML versions of the article.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Psilocybin

View paper Full text (PDF)

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticlePsilocybin

Association of Psilocybin Use in Adolescents with Major Depressive Episode

Shah K, Trivedi C, Kamrai D +2

Europe PMC2022

ArticlePsilocybin

Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain.

Spain A, Howarth C, Khrapitchev AA +3

Europe PMC2015

ArticlePsilocybin

Australia to prescribe MDMA and psilocybin for PTSD and depression in world first.

Haridy R

Europe PMC2023